Botulinum Toxin Type A

CAS 93384-43-1 4 FDA-DMF suppliersBiologic

Overview

Botulinum Toxin Type A, a neurotoxic protein produced by the bacterium Clostridium botulinum, is used for medical and cosmetic purposes to cause muscle relaxation by blocking acetylcholine release at the neuromuscular junction. It is commonly utilized in conditions like chronic migraines, hyperhidrosis, and various forms of muscle spasticity.

Therapeutic areas

NeurologyDermatologyOphthalmology

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.